Suchergebnisse - "Redenti, Sara"

PubPharm (6)

1

Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems

enthalten in: European journal of medicinal chemistry | 2021

von Grieco, I. | Bissaro, M. | Tiz, D. | +11

2

A Triazolotriazine-Based Dual GSK-3β/CK-1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition

enthalten in: ChemMedChem | 2019

von Redenti, S. | Marcovich, I. | De Vita, T. | +13

3

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors

enthalten in: European journal of medicinal chemistry | 2016

von Federico, S. | Ciancetta, A. | Porta, N. | +6

4

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists

enthalten in: Current topics in medicinal chemistry | 2016

von Redenti, S. | Ciancetta, A. | Pastorin, G. | +4

5

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives

enthalten in: PloS one | 2015

von Federico, S. | Redenti, S. | Sturlese, M. | +6

6

Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors : a preliminary structure-activity relationship study

enthalten in: Journal of medicinal chemistry | 2014

von Federico, S. | Ciancetta, A. | Porta, N. | +6

1
[1]